Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.
European Journal of Cancer Care|December 21, 2018
Online support groups offer low-threshold backing for family and friends of patients with prostate cancerAndreas Ihrig, Theresa Renner, Tanja Muck, et al.
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
European Urology|June 2, 2009
Complications following radical cystectomy for bladder cancer in the elderlyMichael Froehner, Maurizio A Brausi, Harry W Herr, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.
Cancer Letters|February 7, 2006
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel, Jana Herrmann, Shuangli Ning, et al.
Cancer Letters|June 28, 2005
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairsSusanne Fuessel, Bernd Weigle, Uta Schmidt, et al.
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Cancer Investigation|January 8, 2011
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma, Thomas Weber, Matthias Meinhardt, et al.
Pageof 25